RM-5038

N/A

Report date: 2022/11/24 20:01:59

Base Information

Drug NameRM-5038
Drug Alias NameRM-6427RM-5061RM-5038RM-4865RM-4864 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor protein-tyrosine kinase modulators
TargetsReceptor protein-tyrosine kinase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRomark Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesRomark Laboratories
Inactive CompaniesN/A
Active IndicationsHepatitis C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A